• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞标志物CD133(prominin-1)在细胞质酪氨酸828和酪氨酸852位点被Src和Fyn酪氨酸激酶磷酸化。

The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.

作者信息

Boivin Dominique, Labbé David, Fontaine Nicolas, Lamy Sylvie, Beaulieu Edith, Gingras Denis, Béliveau Richard

机构信息

Laboratoire de Médecine Moléculaire, Chemistry Department, Université du Québec à Montréal, Canada H3C 3P8.

出版信息

Biochemistry. 2009 May 12;48(18):3998-4007. doi: 10.1021/bi900159d.

DOI:10.1021/bi900159d
PMID:19296573
Abstract

CD133 (prominin-1) is a transmembrane glycoprotein expressed at the surface of normal and cancer stem cells, progenitor cells, rod photoreceptor cells, and a variety of epithelial cells. Although CD133 is widely used as a marker of various somatic and putative cancer stem cells, its contribution to fundamental properties of stem cells such as self-renewal and differentiation remains unknown. CD133 contains a short C-terminal cytoplasmic domain with five tyrosine residues, including a consensus tyrosine phosphorylation site that has not yet been investigated. In this study, we show that CD133 is phosphorylated in human medulloblastoma D283 and Daoy cells, in a Src family kinase-dependent manner. The cytoplasmic domain of CD133 is tyrosine phosphorylated in Daoy cells overexpressing Src and Fyn tyrosine kinases, as well as in vitro using recombinant proteins. Deletion of the C-terminal cytoplasmic domain of CD133 considerably reduced its phosphorylation by Src. To identify the tyrosine phosphorylation sites in CD133, we used matrix-assisted laser desorption/ionization quadrupole time-of-flight (MALDI Q-TOF) and liquid chromatography tandem mass spectrometry (LC-MS/MS). Analysis of tyrosine-phosphorylated CD133 by mass spectrometry and site-directed mutagenesis identified tyrosine-828 and the nonconsensus tyrosine-852 as the major tyrosine phosphorylation sites both in vitro and in intact cells. Identification of CD133 as a substrate for Src-family tyrosine kinases suggests that the cytoplasmic domain of CD133 might play an important role in the regulation of its functions.

摘要

CD133(prominin-1)是一种跨膜糖蛋白,在正常干细胞、癌症干细胞、祖细胞、视杆光感受器细胞以及多种上皮细胞表面表达。尽管CD133被广泛用作各种体细胞和假定的癌症干细胞的标志物,但其对干细胞诸如自我更新和分化等基本特性的作用仍不清楚。CD133含有一个短的C末端胞质结构域,带有五个酪氨酸残基,包括一个尚未研究的共有酪氨酸磷酸化位点。在本研究中,我们表明CD133在人髓母细胞瘤D283和Daoy细胞中以Src家族激酶依赖性方式发生磷酸化。在过表达Src和Fyn酪氨酸激酶的Daoy细胞中以及使用重组蛋白在体外,CD133的胞质结构域发生酪氨酸磷酸化。缺失CD133的C末端胞质结构域可显著降低其被Src磷酸化的程度。为了鉴定CD133中的酪氨酸磷酸化位点,我们使用了基质辅助激光解吸/电离四极杆飞行时间质谱(MALDI Q-TOF)和液相色谱串联质谱(LC-MS/MS)。通过质谱分析酪氨酸磷酸化的CD133以及定点诱变确定,酪氨酸-828和非共有酪氨酸-852是体外和完整细胞中的主要酪氨酸磷酸化位点。鉴定出CD133是Src家族酪氨酸激酶的底物,这表明CD133的胞质结构域可能在其功能调节中起重要作用。

相似文献

1
The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.干细胞标志物CD133(prominin-1)在细胞质酪氨酸828和酪氨酸852位点被Src和Fyn酪氨酸激酶磷酸化。
Biochemistry. 2009 May 12;48(18):3998-4007. doi: 10.1021/bi900159d.
2
SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin.Src家族激酶Fyn使nephrin的胞质结构域磷酸化,并调节其与足突蛋白的相互作用。
J Am Soc Nephrol. 2004 Dec;15(12):3006-15. doi: 10.1097/01.ASN.0000146689.88078.80.
3
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.CD133 通过信号通路的改变抑制神经母细胞瘤细胞分化。
Oncogene. 2011 Jan 6;30(1):97-105. doi: 10.1038/onc.2010.383. Epub 2010 Sep 6.
4
Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.牛胸腺胞质C端Src激酶(CSK)的纯化以及CSK对p56lyn和pp60c-src磷酸化和失活的不同效率的证明。
Biochemistry. 1996 Sep 10;35(36):11874-87. doi: 10.1021/bi9603940.
5
CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.CD133/Src 轴介导体瘤起始特性和头颈部癌症的上皮-间充质转化。
PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.
6
Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133.CD133 标志物对自噬和不对称细胞分裂的分子调控作用。
Cells. 2023 Mar 6;12(5):819. doi: 10.3390/cells12050819.
7
Palmitylation of Src family tyrosine kinases regulates functional interaction with a B cell substrate.Src家族酪氨酸激酶的棕榈酰化调节与B细胞底物的功能相互作用。
Biochem Biophys Res Commun. 1997 May 19;234(2):325-9. doi: 10.1006/bbrc.1997.6638.
8
Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.Src激酶对细胞毒性T淋巴细胞相关分子4的调控
J Immunol. 1999 Feb 1;162(3):1270-7.
9
Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.Fyn和磷脂酰肌醇3激酶通过其src同源2结构域与B细胞表面糖蛋白CD19的特异性结合。
Eur J Immunol. 1995 Oct;25(10):2978-84. doi: 10.1002/eji.1830251040.
10
A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.Eph家族受体酪氨酸激酶Sek中的一个近膜自磷酸化位点介导了与p59fyn的高亲和力相互作用。
Oncogene. 1996 Apr 18;12(8):1727-36.

引用本文的文献

1
Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology.蛋白酪氨酸磷酸酶κ型受体(PTPRK)再探讨:对其结构、功能及病理学的新认识
J Transl Med. 2025 May 12;23(1):534. doi: 10.1186/s12967-025-06496-1.
2
Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?突起小体——一类含有prominin-1/CD133的特殊细胞外囊泡?
J Nanobiotechnology. 2025 Jan 29;23(1):61. doi: 10.1186/s12951-025-03102-w.
3
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.
Prominin-1(CD133)在健康和疾病中参与质膜结构和细胞信号通路动态变化的新兴作用。
Cell Mol Biol Lett. 2024 Mar 26;29(1):41. doi: 10.1186/s11658-024-00554-0.
4
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.CD133 依赖性激活磷酸肌醇 3-激酶/AKT/雷帕霉素靶蛋白信号通路在黑色素瘤进展和耐药中的作用。
Cells. 2024 Jan 26;13(3):240. doi: 10.3390/cells13030240.
5
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.黑色素瘤进展及治疗耐药的机制:癌症干细胞样细胞的作用
Cancers (Basel). 2024 Jan 22;16(2):470. doi: 10.3390/cancers16020470.
6
Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133.CD133 标志物对自噬和不对称细胞分裂的分子调控作用。
Cells. 2023 Mar 6;12(5):819. doi: 10.3390/cells12050819.
7
FYN: emerging biological roles and potential therapeutic targets in cancer.FYN:癌症中新兴的生物学作用和潜在治疗靶点。
J Transl Med. 2023 Feb 5;21(1):84. doi: 10.1186/s12967-023-03930-0.
8
Systemic TM4SF5 overexpression in Apc mice promotes hepatic portal hypertension associated with fibrosis.系统性 TM4SF5 过表达在 Apc 小鼠中促进与纤维化相关的肝门静脉高压。
BMB Rep. 2022 Dec;55(12):609-614. doi: 10.5483/BMBRep.2022.55.12.104.
9
A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.己糖激酶 2 在小细胞肺癌中的非代谢功能:通过增加 USP11 介导的 CD133 稳定性促进癌细胞干性。
Cancer Commun (Lond). 2022 Oct;42(10):1008-1027. doi: 10.1002/cac2.12351. Epub 2022 Aug 16.
10
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.microRNA-21 调控胰腺导管腺癌细胞的干性。
Int J Mol Sci. 2022 Jan 24;23(3):1275. doi: 10.3390/ijms23031275.